Gabapentin Capsule
Product Images NDC 71205-808

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71205-808). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gabapentin 01)

Chemical structure of gabapentin showing a cyclohexane ring attached to an amino group (CH2NH2) and a carboxyl group (CH2CO2H).*

FDA Label Image

Figure 1 (Gabapentin 02)

A line graph showing the mean pain score over 8 weeks comparing placebo and Gabapentin 3600 mg/day. It includes a 4-week dose titration period followed by a 4-week fixed dose period, with mean pain scores decreasing more substantially in the Gabapentin group than placebo.*

FDA Label Image

Figure 2 (Gabapentin 03)

A line chart showing mean pain scores over 7 weeks during a 3-week dose titration period followed by a 4-week fixed dose period. It compares placebo and two doses of gabapentin (1800 mg/day and 2400 mg/day). Pain scores decrease more with gabapentin treatments than with placebo over time.*

FDA Label Image

Figure 3 (Gabapentin 04)

A bar chart labeled "Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies" comparing placebo (PBO) and different Gabapentin (GBP) dosages across two studies. Study 1 shows 12% responders for PBO and 29% for GBP 3600. Study 2 shows 14% responders for PBO, 32% for GBP 1800, and 34% for GBP 2400. Statistical significance is indicated with p-values: **p < 0.01, ***p < 0.001.*

FDA Label Image

Figure 4 (Gabapentin 05)

A scatter plot presenting differences in percentage on the y-axis relative to daily gabapentin dose in mg on the x-axis. Data points represent results from three different studies labeled as study a, study b, and study c, distinguished by solid and hollow squares. The plot shows values at doses of 600, 900, 1200, and 1800 mg.*

FDA Label Image

71205-808-90 (Gabapentin 07)

Label for Gabapentin 400 mg capsules by Proficient Rx LP. The label includes product instructions to provide a Medication Guide with dispensing. Capsules contain 400 mg gabapentin, USP, with white to off-white powder inside size "0" hard gelatin capsules having an opaque orange cap and body imprinted with 'SG' and '181' in black ink. Manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.